Key to p53 ability to mediate its multiple cellular functions lies in its stability. In the present study we have elucidated the mechanism by which Mdm2 regulates p53 degradation. Using in vitro and in vivo ubiquitination assays we demonstrate that Mdm2 association with p53 targets p53 ubiquitination. Exposure of cells to UVirradiation inhibits this targeting. Mdm2 which is de®cient in p53 binding failed to target p53 ubiquitination, suggesting that the association is essential for Mdm2 targeting ability. While mdm2-p53 complex is found in non-stressed cells, the amount of p53-bound mdm2 is decreased after UV-irradiation, further pointing to the relationship between mdm2 binding and p53 level. Similar to Swiss 3T3 cells, the dissociation of mdm2-p53 complex was also found in UV-treated Scid cells, lacking functional DNA-PK, suggesting that DNA-PK is not sucient for dissociating mdm2 from p53. Together our studies point to the role of Mdm2, as one of p53-associated proteins, in targeting p53 ubiquitination.
The p53 tumor suppressor protein is a potent transcription factor, which is activated and accumulated in response to dierent DNA-damaging agents (Haner and Oren, 1995; Kastan et al., 1991; Kern et al., 1991) , leading to cell cycle arrest, or to induction of apoptosis (Levine, 1997; Ko and Prives, 1996) . Disruption of this pathway occurs in a wide variety of human cancers, and is highly correlated with the development of the tumorigenic phenotype (Hollstein et al., 1991; Harris, 1996; Levine, 1997) . Accumulation of p53 by DNA damage and stress stimuli is predominantly determined by stabilization of this otherwise short-living protein (Maltzman and Czyzyk, 1984; Brown and Pagano, 1997) .
Both proteasome and calpain pathways have been implicated in p53 degradation (Maki and Howley, 1997; . Among proteins shown to aect p53 stability are HPV-16-E6 (Schener et al., 1990; Huibregtse et al., 1991) , WT-1 (Maheswaran et al., 1995) , E1B/E4orf6 (Querido et al., 1997) , SV40T antigen (Tiemann et al., 1995) , Mdm2 (Haupt et al., 1997; and Jun N-terminal kinase -JNK . While E1B, SV40 T antigen, and WT-1 stabilize p53, E6, JNK and Mdm2 binding to p53 has been implicated in targeting its degradation. Over-expression of Mdm2 was shown to destabilize p53 although the mechanism of destabilization is largely unknown. The eect of Mdm2 was not observed in the cells treated with proteasome inhibitors Haupt et al., 1997; Chang et al., 1998) suggesting that Mdm2 is likely to mediate p53 degradation via proteasome rather than calpain pathway. Accordingly, abrogation of p53-Mdm2 interaction is expected to diminish p53 degradation and could serve as a putative mechanism of stress-induced stabilization of p53. Mdm2 ability to target p53 degradation also depends on its own availability since it is targeted for degradation by the p19 ARF (Zhang et al., 1998) . Among key factors involved in determining p53 ability to associate with other cellular proteins is its phosphorylation pattern and respective conformation . p53 can be phosphorylated in vitro at multiple sites by a variety of protein kinases, including casein kinase II (Meek et al., 1990) cdc2 kinase (Bischo et al., 1990) , mitogen-activated protein kinase (Milne et al., 1994) , protein kinase C (Baudier et al., 1992) , protein kinase A , DNAdependent protein kinase (Lees-Miller et al., 1990) and Jun N-terminal kinase (Milne et al., 1995; Adler et al., 1997; Hu et al., 1997) . Both DNA-PK and JNK are stress-activated and phosphorylate p53 on its Nterminal sites. One of the putative phosphoacceptor sites that might be involved in protection of p53 from degradation is Ser15 as p53 protein mutated at this site exhibits lower stability when compared to its wild type counterpart (Shieh et al., 1997) . This phosphorylation was attributed to DNA-PK and results in protection of p53 from association with Mdm2 (Shieh et al., 1997) . Interestingly however, while g-irradiation induced phosphorylation of p53 at Ser15 (Siciliano et al., 1997) UV-irradiation led to phosphorylation at aa 392 (Lu et al., 1998) .
Poly-ubiquitination, i.e. covalent attachment of multiple ubiquitin residues to e-lysil amino-groups serves as a mark for proteasome recognition (Ciechanover, 1994; Weissman, 1997) . To elucidate the regulation of p53 targeting for the ubiquitin-proteasome pathway we have determined the role of Mdm2 in targeting p53 ubiquitination, as a pre-requisite step for its subsequent degradation. Mdm2 ability to target p53 ubiquitination in vitro was assessed via incubation of baculovirus produced Mdm2 with his p53, followed by extensive washes and ubiquitination with the aid of Mdm2-free rabbit reticulocyte lysate. Degree of p53 ubiquitination is monitored by using HA antibodies that detect the bacterially expressed and puri®ed HAtagged Ubiquitin, which is added to the reaction. Thus, HA-reactive smear re¯ects p53 speci®c ubiquitination since this smear is not found in the reaction without p53 (Figure 1 right lane) . Under these conditions, if tight association between Mdm2 and p53 would mark the protein for ubiquitination, the respective increase in poly-ubiquitinated p53 is expected. As shown in Figure  1 , preincubation of Mdm2 with p53 increases the extent of p53 ubiquitination. Such targeting was not observed when mutant Mdm2, which lacks its association domain with p53, was used (Figure 1 ), suggesting that association is an essential requirement for Mdm2 targeting of p53 ubiquitination. Mdm2 targeted p53 ubiquitination is dose-dependent (not shown). These data are in line with the results of Haupt et al. (1977) and which have demonstrated that p53 binding is indispensable for Mdm2 to accelerate p53 degradation.
To further elucidate the role of Mdm2 in targeting p53 ubiquitination we have used proteins of Oslch cells that express high levels of Mdm2 . Adding Olsch cells extract to his p53 prior to the ubiquitination reaction resulted in high and ecient level of p53 ubiquitination (Figure 1 ). Immunodepletion of Mdm2 from these extracts lowered level of p53 ubiquitination, as compared with mock immunodepletion using normal rabbit serum. These data further demonstrate the targeting role of Mdm2.
In order to con®rm the results of in vitro ubiquitination assays we evaluated the role of Mdm2 in ubiquitination of p53 in vivo. To detect in vivo ubiquitination of exogenous his p53 we utilized the coexpression assay described by Treier et al. (1994) in which either ubiquitin or the substrate is tagged with six His-residues allowing its puri®cation under stringent denaturing conditions. Fusing His-tag to carboxy-terminal of p53 signi®cantly increased its steady-state level whereas addition of hexahistidine residues at N-terminus did not alter the half-life of p53 protein, and was respectively used in our experiments.
Co-transfection of his p53 and ubiquitin-HA expression vectors into Balb/3T3 ®broblasts treated with the proteasome inhibitor MG132 was followed by purification of his p53 on nickel resins. While immunoblotting using anti-p53 PAb421 antibody allow to identify expression of nickel-puri®ed his p53 (Figure 2a , lower panel, lanes 2 ± 3), co-expression of ubiquitin-HA expression vector allows to detect the smear of slower-migrating proteins when probing the upper part of the ®lter with anti-HA antibody (upper panel, lane 3). These proteins represent speci®c p53-ubiquitin-HA conjugates since they cannot be detected when ubiquitin-HA or his p53 were expressed alone (lanes 1 and 2, respectively).
In vivo ubiquitination assay performed in p53 null 10.1 ®broblasts via transfection of p53 cDNA and HAtagged Ub in the presence of the proteasome inhibitor MG-132 revealed lower degree of p53 ubiquitination than in Balb/3T3 ®broblasts ( Figure 2b , lane 2). Cotransfection with Mdm2 expression vector led to a marked increase in the level of p53 ubiquitination (Figure 2b, lane 3) . Expression of mutant Mdm2, which lacks p53 binding site (Wu et al., 1995) , did not cause such increase (lane 4). These data suggest that Mdm2 targets the enhanced ubiquitination of exogenous p53. Our results are in agreement with previously demonstrated failure of this mutant Mdm2 to shorten p53 half-life .
To follow the eect of Mdm2 on the ubiquitination of endogenous p53 we transfected Balb/3T3 ®broblasts ( 6610 7 ) with hexahistidine-tagged ubiquitin expression vector. About 2% of the total lysate volume were analysed for the steady state level of p53 by Western blot (Figure 2c, lower panel) . After puri®cation of ubiquitinated proteins on nickel beads, the bound proteins were analysed via immunoblotting with PAb 421 (Figure 2c, upper panel) . Both immunoblots were performed and developed simultaneously, and were quanti®ed in order to calculate the ratio between ubiquitinated and total p53. Assuming a complete recovery of ubiquitinated p53 from nickel columns, we estimate that 12.8% of p53 is ubiquitinated in the 3T3 ®broblasts before UV vs 4.4% that is ubiquitinated after UV-irradiation (compare lanes 2 vs 3). Coexpression of Mdm2 (lane 4) led to 50% increase in p53 that is covalently bound to ubiquitin moiety. This increase was diminished in UV-treated cells (lane 5). We conclude that UV irradiation protected p53 from Mdm2-dependent targeting for ubiquitination.
Since the association between p53 and Mdm2 is an essential requirement for Mdm2 ability to target p53 ubiquitination we have followed up the complex of Figure 1 Mdm2 targets in vitro ubiquitination of p53. Human p53 cDNA has been cloned into pET15b vector (Novagen) between NdeI and BamHI sites. Recombinant his p53 proteins were expressed in BL21 bacterial strain and puri®ed and refolded as described . Mdm2 baculovirus-based expression vectors and Mdm2 puri®cation from infected Sf9 cells have been described (Wu et al., 1995) . Whole cell extracts were prepared as described elsewhere . The ability of Mdm2 to target p53 ubiquitination was assessed in vitro ubiquitination assay as previously described . Brie¯y, bacterially expressed his p53 (2 mg) bound to NTA beads was incubated with Mdm2 as a single targeting component or with protein extracts from cells (immunodepleted of Mdm2 or mock immunodepleted using normal rabbit serum) as indicated at 28C. The control reaction without substrate (right lane) was performed as described . After extensive washes, ubiquitination was carried out with reticulocyte lysates pre-depleted of Mdm2 and supplemented with bacterially produced HA-tagged ubiquitin (HA cloned at the NH 2 end of the ubiquitin cDNA), ATP and ATPgS (used to prevent degradation) as described (Fuchs et al., 1996) . Beads bound proteins were puri®ed under denaturing conditions, separated by 8% sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to Hybond C nitrocellulose ®lter (Amersham). Degree of ubiquitination is measured through the use of immunoblots probed with anti-HA antibody (upper panel). Lower panel represents Ponceau S staining of the same membrane Figure 2 Mdm2 targets in vivo ubiquitination of p53. (a) P53 in vivo ubiquitination in Balb/3T3. Amino-terminal his-tagged p53 expression vector was constructed by PCR-mediated cloning of rat p53 cDNA into pcDNA3 vector (Invitrogen). All p53 sequences were veri®ed by dideoxy sequencing. His-p53 (4 mg) was co-transfected into mouse ®broblasts together with ubiquitin-HA expression vector (3 mg) by lipofection (DOTAP, Boehringer Mannheim). 24 h later cell were incubated with 10 mM MG132 (Peptide International). Cells were lysed with 6 M guanidinium HCl and his-tagged protein were puri®ed by nickel resins as described by Treier et al. (1994) , separated by 8% sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred on Hybond C nitrocellulose ®lter (Amersham). Filter was cut just above 55 kD protein molecular weight marker (Promega) and its lower part was analysed via immunoblotting using anti-p53 PAb421 antibody to identify nickel-puri®ed his-p53. The upper part of the ®lter was probed with anti-HA antibody (BabCo) allowing detection of smear, which represent slower-migrating ubiquitin-HA conjugates. (b) P53 in vivo ubiquitination in 10.1 cells is increased upon co-transfection with Mdm2. In vivo ubiquitination assay was performed in p53 null 10.1 cells as described above. Two mg of Mdm2 encoding plasmids were used for co-transfections and the overall amount of CMV promoter-containing plasmids has been equilibrated with pcDNA3 empty vector to 10 mg per 100 mm plate. (c) Mdm2 increase in vivo ubiquitination of endogenous p53. To analyze the ubiquitination of endogenous p53, 6610
7 Balb/3T3 ®broblasts were transfected with hexahistidine-tagged ubiquitin expression construct (5 mg per 100 mm plate). Cells were irradiated with UV-C (50 J/m 2 ) as indicated 8 h prior to harvesting. Small fraction (2%) of total lysate was analyzed for p53 level via immunoblot with PAb 421 antibody (lower panel). The rest of the lysates was used to purify the ubiquitinated proteins by nickel resins. Eluates from nickel column were analyzed by immonoblotting using using anti-p53 PAb421 antibody (upper panel). The relative amount of ubiquitinated p53 (% of total) was calculated from densitometeric analysis of the blots shown (assuming 100% recovery from the nickel column) Figure 3 Mdm2 association with p53 in vivo is impaired after UV treatment. (a) Swiss-3T3 ®broblasts were grown in DMEM supplemented with 10% of calf serum and treated with UV (50 J/m 2 ) as indicated. Whole cell extracts were prepared at dierent time points after UV irradiation as described elsewhere . For immunoprecipitation, 2 mg of extracts were precleared by incubation with 40 ml of protein G beads (Gibco BRL). Supernatants were incubated with PAb 421 monoclonal antibody against p53 and protein G-beads overnight. After extensive washes with PBS, the immunopuri®ed proteins were eluted with Laemmli buer, resolved by 8% sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred on Hybond C nitrocellulose ®lter (Amersham). Immunoblotting was performed with PAb421 (lower panel) or 2A10 (upper panel) monoclonal antibodies. The steady state level of Mdm2 in 100 mg of whole cell extract is also depicted. (b) Scid cells were maintained in DMEM supplemented with 10% of bovine calf serum. UV treatment, immunoprecipitations and immunoblotting analysis were performed as described above Mdm2-p53 in mouse ®broblasts. To this end, protein extracts prepared from Swiss 3T3 ®broblasts were immunoprecipitated with antibodies to p53 followed up with immunoblots with antibodies to Mdm2. The amount of Mdm2 in p53 precipitates sharply decreased within 30 min after UV-irradiation (not shown) and up to 8 h after exposure (Figure 3a) . This ®nding suggest that changes in p53 which occurred shortly after UV-irradiation led to partial Mdm2 dissociation and lack of targeting p53 for ubiquitination, for at least 8 h.
Since phosphorylation-dependent changes in p53 conformation in response to UV treatment may be involved in decreased p53 anity to Mdm2, we have examined the role of DNA damage-activated kinase, DNA-PK. Immunoprecipitation experiments performed in Scid cells, which lack functional DNA-PK, revealed that the pattern of p53 association with Mdm2 was identical to what was found in DNA-PK functional cells (Figure 3b ). These observations suggest that DNA-PK is not sucient for Mdm2 dissociation from p53 upon UV treatment of these cells. It is also possible that there is another UV-inducible kinase, which carries out this phosphorylation in the absence of DNA-PK. Indeed, accumulation of p53 has been observed in Scid cells (Rathmell et al., 1997) .
The underlying mechanisms for the regulation of p53 stability have been under intense investigation, as it is central for this multifunctional protein's activity. Changes in the stability of p53 has been documented to occur under two independent circumstances; ®rst, cells that have been exposed to DNA damaging agents found to contain higher amount of p53, which result from increased p53 stability. Second is the ®nding that mutant forms of p53 exhibit prolonged half-life.
Important contribution to our understanding of mechanism underlying changes of p53 half life in damaged cells has been provided by the ®nding that Mdm2 play important role in p53 degradation via its association with p53, although the mechanism of this eect remained unclear. Here we demonstrate that this association targets p53 ubiquitination. Our in vitro observations were supported by in vivo ubiquitination assays and through monitoring of Mdm2-p53 complexes at dierent time points after cell exposure to stress. The present study demonstrate that association between p53 and mdm2 is similar in cells that lack functional DNA-PK, suggesting that other kinases are required for UV-irradiation-mediated dissociation of mdm2 from p53. Future studies should reveal which is the primary kinase that aects p53 association with Mdm2. At this point we cannot exclude that multiple kinases contribute to these stress mediated changes. Identi®cation of those kinases will be very important for our understanding of mechanisms underlying the regulation of p53 stability.
Mdm2 is not the only regulatory component of p53 stability, as concluded from existence of cell lines in which both Mdm2 and p53 are over-expressed (Cordon Cardo et al., 1994) . Respectively, the higher stability of mutant p53 is expected to depend on altered association with cellular and viral proteins due to mutation-altered conformation.
